N9X.F New Nordic Healthbrands AB (publ)
- Market cap
- EUR 8.15M
- P/E
- 18.8x
- P/B
- 0.83x
- ROE
- 3.1%
- Dividend yield
- 1.74%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is N9X.F undervalued?
Graham numberN9X.F trades 16.9% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
New Nordic Healthbrands AB (publ) fundamental analysis
No fundamental analysis for New Nordic Healthbrands AB (publ) yet.
New Nordic Healthbrands AB (publ) stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About New Nordic Healthbrands AB (publ)
New Nordic Healthbrands AB (publ) manufactures and sells dietary supplements, herbal remedies, and related personal care products in the Nordic countries, rest of Europe, North America, and internationally. The company offers body care, dietary supplements, facial care, assortment, and natural magic trio products; hair volume series, dietary supplements, shampoo and conditioner, hair care, and range products; vitality products, such as vitamins and minerals, body, fish oil a…
Full company profileNew Nordic Healthbrands AB (publ) financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
New Nordic Healthbrands AB (publ) annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 515M | 488M | 534M | 550M | 576M | 587M |
| Gross Profit | 350M | 319M | 348M | 355M | 370M | 371M |
| Operating Income | 28.5M | -4.75M | -3.17M | -4.45M | 15.1M | 10.7M |
| EBITDA | - | -2.00M | -1.77M | -1.43M | 17.1M | 13.4M |
| Net Income | 21.3M | -2.82M | -6.19M | -7.70M | 8.20M | 3.32M |
| EPS | 3.44 | -0.46 | -1.00 | -1.24 | 1.32 | 0.54 |
| Balance Sheet | ||||||
| Total Assets | 238M | 252M | 249M | 249M | 246M | 281M |
| Total Liabilities | 118M | 139M | 143M | 148M | 143M | 172M |
| Shareholders' Equity | 120M | 113M | 106M | 101M | 103M | 109M |
| Cash & Short-term Investments | 11.9M | 10.7M | 13.8M | 15.2M | 16.5M | 7.30M |
| Cash Flow | ||||||
| Operating Cash Flow | -7.87M | -15.5M | 28.0M | -5.40M | 8.39M | -11.5M |
| Capital Expenditure | 2.66M | 2.95M | 3.07M | 4.43M | 3.47M | 2.16M |
| Free Cash Flow | -10.5M | -18.4M | 25.0M | -9.83M | 4.92M | -13.6M |
| Ratios | ||||||
| ROE | 17.7% | -2.5% | -5.8% | -7.6% | 7.9% | 3.1% |
| ROA | 8.9% | -1.1% | -2.5% | -3.1% | 3.3% | 1.2% |
| Net Profit Margin | 4.1% | -0.6% | -1.2% | -1.4% | 1.4% | 0.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
New Nordic Healthbrands AB (publ) dividends
- Dividend yield
- 1.74%
- Forward dividend
- 0.02 EUR
- Payout ratio
- -
- Ex-dividend date
- Apr 30, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | SEK 7.74M | 1.25 | - |
| 2021 | SEK 9.29M | 1.50 | 43.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns New Nordic Healthbrands AB (publ)
- Insiders 53.53%
- Institutions 26.93%
- Public & others 19.55%
- Shares outstanding 6.20M
- Free float 801K
New Nordic Healthbrands AB (publ) company profile
- Company name
- New Nordic Healthbrands AB (publ)
- Ticker
- N9X.F
- ISIN
- SE0001838038
- Exchange
- Frankfurt Exchange
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Employees
- 82
- Fiscal year end
- December
- Address
- Hyllie Boulevard 34, Malmö, Sweden, 215 32
- Phone
- 46 40 23 95 20
- Website
- newnordic.se
About New Nordic Healthbrands AB (publ)
New Nordic Healthbrands AB (publ) manufactures and sells dietary supplements, herbal remedies, and related personal care products in the Nordic countries, rest of Europe, North America, and internationally. The company offers body care, dietary supplements, facial care, assortment, and natural magic trio products; hair volume series, dietary supplements, shampoo and conditioner, hair care, and range products; vitality products, such as vitamins and minerals, body, fish oil and omega-3, menopause, sleep and relaxation, men's health, and magnesium products; detox, digestion, and weight loss products. It sells its products under the NEW NORDIC brand through pharmacies, department stores, travel retailers, health stores, e-commerce, and direct to consumers. New Nordic Healthbrands AB (publ) was founded in 1990 and is headquartered in Malmö, Sweden.
New Nordic Healthbrands AB (publ) management
4- Mr. Karl Kristian Bergman JensenCo-Founder, CEO & Director · born 1962
- Mr. Marinus Blabjerg SorensenCo-Founder & Director · born 1951
- Mr. Ivan RuscicChief Financial Officer
- Claes LibellGroup Financial Controller & Investor Relations